Growth Opportunities in the Western European IVD Industry, Forecast to 2021

Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the self-monitoring blood glucose (SMBG) segment's growth in emerging markets is severely dampened by the slowing growth from reimbursement reductions in Western Europe.The broad applicability of POCT, combined with downward pricing trends enabled by microfluidics integration, supports the long-term growth of this segment. The Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Eastern European markets.

The recent success of companion diagnostic tests and personalised medicine is driving the uptake of various tests in an aim to save costs, thus opening up an opportunity to expand the test menus in existing installs. Diagnostic testing will continue to move towards process simplicity and decentralisation. IVD market participants are expected to employ a diverse set of strategies rather than rely on comprehensive product portfolios to grow their businesses. Companies are also gaining new market access through acquisitions, and this has intensified competition among tier 1 participants.

This study offers comprehensive information on every aspect of the IVD market. It is segmented into 8 subdivisions, namely, immunochemistry, POCT, SMBG, molecular diagnostics, clinical microbiology, haemostasis, hematology, and tissue diagnostics. Discussion on key trends and opportunities and company profile analysis by segment are also provided. In addition, there are dedicated country chapters for the key Western European markets (Germany, France, the United Kingdom, Spain, Italy, Benelux, and Scandinavia) and a snapshot of the regulatory policies awaiting to transform the industry.

Table of Contents

1. Executive Summary
Western European IVD Market Dynamics
Key Trends Driving the Market
Strategic Imperatives for IVD Companies
8 Big Market Directions
Scope and Segmentation
2. Market Overview
Market Definition—Diagnostics for Health
IVD Value Chain across Patient Continuum
Segment Overview
3. Market Dynamics—Western Europe
How Do IVDs Reach Patients in Europe?
Major Regulatory Developments and Future Implications
Reimbursement Policies for IVD across Western Europe (EU5)
Stepping Stones that Promote IVD among the Public (with Government Backing)
4. Trend Analysis—Western European IVD Market
Key Trend 1—Consolidation of Labs
Key Trend 2—Decentralized Laboratory Testing
5. Emerging Technologies in the Western European IVD Market
Emerging Technology 1—Companion Diagnostics
Participants are Expanding Their Product Portfolios to Include Companion Diagnostics
Emerging Technology 2—Liquid Biopsy
Participants are Expanding Their Product Portfolios to Include Liquid Biopsy
Other Key Emerging Technologies
6. Regional Analysis—Western Europe
Regional Perspective
Market Analysis—Germany
Market Analysis—France
Market Analysis—Italy
Market Analysis—The United Kingdom
Market Analysis—Spain
Market Analysis—Benelux
Market Analysis—Scandinavia
Market Analysis—Rest of Europe
Market Analysis—Rest of Europe (Poland)
7. Drivers and Restraints—IVD Market
Market Drivers
Market Restraints
8. Growth Opportunities and Companies to Action
Growth Opportunity 1—Infectious Disease Diagnostics
Growth Opportunity 2—Data-driven Digital POCT
Growth Opportunity 3—Personalized Medicine through Companion Diagnostics and Pharmacogenomics
Growth Opportunity 4—Genetic Testing
Growth Opportunity 5—Geographical Expansion to Eastern Europe
9. Revenue Forecast—IVD Market
Western European IVD Market by Segment
Western European IVD Market by Country
Western European IVD Market by Market Participants
Key Mergers, Acquisitions, and Partnership Assessment
Western European IVD Market—Revenue Forecast
10. Segment Analysis—IVD Market
Western European IVD Market—Segment Life Cycle Analysis
11. Immunochemistry Segment Analysis
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
12. Molecular Diagnostics Segment Analysis
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
13. POCT Segment Analysis
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
14. Tissue Diagnostics Segment Analysis
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
15. Self-monitoring Blood Glucose Segment Analysis
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
16. Clinical Microbiology Segment Analysis
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
6Key Trends
Growth Opportunities
17. Haemostasis Segment Analysis
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
18. Haematology Segment Analysis
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
19. Conclusion
Top Predictions for the Western European IVD Market
Legal Disclaimer
20. The Frost & Sullivan Story

Infographic



List of Figures & Charts

1. IVD Market: Reimbursement Scenario, Western Europe, 2016
2. IVD Market: Healthcare Structure, Western Europe, 2016
3. IVD Market: Key Drivers, Western Europe, 2017–2021
4. IVD Market: Key Restraints, Western Europe, 2017–2021
5. IVD Market: Key M&A and Partnership Assessment, Western Europe, 2016
6. Immunochemistry Segment: Key Participants, Western Europe, 2016
7. Immunochemistry Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
8. Molecular Diagnostics Segment: Key Participants, Western Europe, 2016
9. Molecular Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
10. POCT Segment: Key Participants, Western Europe, 2016
11. POCT Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
12. Tissue Diagnostics Segment: Key Participants, Western Europe, 2016
13. Tissue Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
14. SMBG Segment: Key Participants, Western Europe, 2016
15. SMBG Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
16. Clinical Microbiology Segment: Key Participants, Western Europe, 2016
17. Clinical Microbiology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
18. Haemostasis Segment: Key Participants, Western Europe, 2016
19. Haematology Segment: Key Participants, Western Europe, 2016
20. Haematology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021


1. IVD Market: Technology Adoption, Western Europe, 2016
2. IVD Market: Percent Revenue Breakdown by Segment, Western Europe, 2016
3. IVD Market: Percent Revenue Breakdown by Country, Western Europe, 2016
4. IVD Market: Percent Revenue Breakdown, Western Europe, 2016
5. IVD Market: Revenue Forecast, Western Europe, 2016–2021
6. IVD Market: Segment Life Cycle Analysis, Western Europe, 2016
7. Immunochemistry Segment: Revenue Forecast, Western Europe, 2016–2021
8. Immunochemistry Segment: Percent Revenue Breakdown, Western Europe, 2016
9. Molecular Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021
10. Molecular Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016
11. POCT Segment: Revenue Forecast, Western Europe, 2016–2021
12. POCT Segment: Percent Revenue Breakdown, Western Europe, 2016
13. Tissue Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021
14. Tissue Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016
15. SMBG Segment: Revenue Forecast, Western Europe, 2016–2021
16. SMBG Segment: Percent Revenue Breakdown, Western Europe, 2016
17. Clinical Microbiology Segment: Revenue Forecast, Western Europe, 2016–2021
18. Clinical Microbiology Segment: Percent Revenue Breakdown, Western Europe, 2016
19. Haemostasis Segment: Revenue Forecast, Western Europe, 2016–2021
20. Haemostasis Segment: Percent Revenue Breakdown, Western Europe, 2016
21. Haemostasis Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
22. Haematology Segment: Revenue Forecast, Western Europe, 2016–2021
23. Haematology Market: Percent Revenue Breakdown, Western Europe, 2016



Keyword1

Keyword2

Keyword3

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.